COMMUNIQUÉS West-GlobeNewswire

Yield10 Bioscience Announces Delisting from Nasdaq
15/05/2024
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that Company has received a final delisting notice [...]
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
15/05/2024
MIAMI, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, [...]
Sienna Announces May Dividend
15/05/2024
MARKHAM, Ontario, May 15, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) for [...]
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
15/05/2024
GLEN ALLEN, Va., May 15, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and [...]
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
15/05/2024
TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the “Company” or “PaxMedica”) ( OTC:PXMD ) , a biopharmaceutical company dedicated to advancing treatments for neurological disorders, [...]
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
15/05/2024
– Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – MIAMI, May 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a [...]
Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting
15/05/2024
LAWRENCEVILLE, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN) , a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, [...]
Safety Shot, Inc. (Nasdaq: SHOT) Announces Strategic C-Store Plans in Los Angeles with 7-Eleven
15/05/2024
JUPITER, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) is thrilled to announce it will be introducing Safety Shot into 50 targeted 7-Elevens in Los Angeles in June. Safety Shot is the world's [...]
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
15/05/2024
U.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results expected during 1H’25 Strengthened leadership team with the [...]
Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis
15/05/2024
HAMPTON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first patient has been dosed in the Company’s Phase 2 subcutaneous study of barzolvolimab in prurigo [...]
Lifeward Reports First Quarter 2024 Financial Results
15/05/2024
Q1’24 revenue of $5.3M is up 340% vs. Q1’23 and at the midpoint of Lifeward’s guidance range Newly established Medicare payment for ReWalk Personal Exoskeleton favorably impacts Q1’24 results Medicare Administrative [...]
BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering
15/05/2024
PHILADELPHIA and VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update
15/05/2024
Fifth Data and Safety Monitoring Board (DSMB) meeting recommended the continuation, without modifications, of the Phase 2b/3 NAVIGATE study of belapectin in liver cirrhosis due to metabolic dysfunction-associated [...]
Osmol Therapeutics Appoints Christopher S. Eklund to its Board of Directors
15/05/2024
NEW HAVEN, Conn., May 15, 2024 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for chemotherapy-induced peripheral [...]
Soleno Therapeutics Stands with the Prader-Willi Syndrome Community
15/05/2024
This Prader-Willi Syndrome Awareness Day, May 15, join Soleno Therapeutics in sharing messages of hope and kindness for the Prader-Willi syndrome community REDWOOD CITY, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Soleno [...]
MIMEDX to Participate in Upcoming Investor Conferences
15/05/2024
MARIETTA, Ga., May 15, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences [...]
PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
15/05/2024
Provided Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer Expanded Global Intellectual Property [...]
The Doggone Foundation donates $150K to the MUHC Foundation to support breast cancer research
15/05/2024
The gift supports liquid biopsy research for breast cancer, an innovative screening test that detects tumour DNA via a sample of blood MONTREAL, May 15, 2024 (GLOBE NEWSWIRE) -- As part of its mission to support health [...]
La Fondation Doggone fait un don de 150 000 $ à la Fondation du CUSM pour la recherche sur le cancer du sein
15/05/2024
Ce don soutient la recherche sur la biopsie liquide pour le cancer du sein, un test de dépistage novateur qui détecte l’ADN des tumeurs à partir d’un échantillon de sang MONTRÉAL, 15 mai 2024 (GLOBE NEWSWIRE) -- Dans le [...]

Pages